Genetic characterization of the beta-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus.

beta-Glucuronidase activity (encoded by the gus gene) has been characterized for the first time from Ruminococcus gnavus E1, an anaerobic bacterium belonging to the dominant human gut microbiota. beta-Glucuronidase activity plays a major role in the generation of toxic and carcinogenic metabolites in the large intestine, as well as in the absorption and enterohepatic circulation of many aglycone residues with protective effects, such as lignans, flavonoids, ceramide and glycyrrhetinic acid, that are liberated by the hydrolysis of the corresponding glucuronides. The complete nucleotide sequence of a 4537 bp DNA fragment containing the beta-glucuronidase locus from R. gnavus E1 was determined. Five ORFs were detected on this fragment: three complete ORFs (ORF2, gus and ORF3) and two partial ORFs (ORF4 and ORF5). The products of ORF2 and ORF3 show strong similarities with many beta-glucoside permeases of the phosphoenolpyruvate : beta-glucoside phosphotransferase systems (PTSs), such as Escherichia coli BglC, Bacillus subtilis BglP and Bacillus halodurans PTS Enzyme II. The product of ORF5 presents strong similarities with the amino-terminal domain of Clostridium acetobutylicum beta-glucosidase (bglA). The gus gene product presents similarities with several known beta-glucuronidase enzymes, including those of Lactobacillus gasseri (69%), E. coli (61%), Clostridium perfringens (59%) and Staphylococcus aureus (58%). By complementing an E. coli strain in which the uidA gene encoding the enzyme was deleted, it was confirmed that the R. gnavus gus gene encodes the beta-glucuronidase enzyme. Moreover, it was found that the gus gene was transcribed as part of an operon that includes ORF2, ORF3 and ORF5.

[1]  T. Klaenhammer,et al.  Identification and Cloning of gusA, Encoding a New β-Glucuronidase from Lactobacillus gasseriADH , 2001, Applied and Environmental Microbiology.

[2]  M. Fons,et al.  Ruminococcin A, a New Lantibiotic Produced by aRuminococcus gnavus Strain Isolated from Human Feces , 2001, Applied and Environmental Microbiology.

[3]  N. Misawa,et al.  Effects of beta-glucuronidase-deficient and lycopene-producing Escherichia coli strains on formation of azoxymethane-induced aberrant crypt foci in the rat colon. , 1999, Biochemical and biophysical research communications.

[4]  M. Jenab,et al.  Flaxseed and lignans increase cecal beta-glucuronidase activity in rats. , 1999, Nutrition and cancer.

[5]  B. Burchell,et al.  UDP-glucuronosyltransferases: a family of detoxifying enzymes. , 1990, Trends in pharmacological sciences.

[6]  J. Doré,et al.  Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.

[7]  R. Jefferson,et al.  The GUS reporter gene system , 1989, Nature.

[8]  B. Drasar,et al.  Intestinal bacteria and the hydrolysis of glycosidic bonds. , 1971, Journal of medical microbiology.

[9]  T. Akao.  Purification and characterization of glycyrrhetic acid mono-glucuronide beta-D-glucuronidase in Eubacterium sp. GLH. , 1999, Biological & pharmaceutical bulletin.

[10]  S. Salzberg,et al.  Evidence for lateral gene transfer between Archaea and Bacteria from genome sequence of Thermotoga maritima , 1999, Nature.

[11]  M. Hattori,et al.  Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Akao.  Competition in the metabolism of glycyrrhizin with glycyrrhetic acid mono-glucuronide by mixed Eubacterium sp. GLH and Ruminococcus sp. PO1-3. , 2000, Biological & pharmaceutical bulletin.

[13]  G. Dutton.  Developmental aspects of drug conjugation, with special reference to glucuronidation. , 1978, Annual review of pharmacology and toxicology.

[14]  H. Jeong,et al.  Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. , 2002, Pharmacological research.

[15]  Dong-Hyun Kim,et al.  Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities , 2000, Archives of pharmacal research.

[16]  R. Lathe.  Phd by thesis , 1988, Nature.

[17]  Takuji Tanaka,et al.  Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane‐induced colon carcinogenesis in male F344 rats , 2002, International journal of cancer.

[18]  B. Drasar,et al.  Bacteria and aetiology of cancer of large bowel. , 1971, Lancet.

[19]  S. Gallagher.  GUS protocols: using the GUS gene as a reporter of gene expression. , 1992 .

[20]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[21]  T. Fujisawa,et al.  Influence of bile salts on beta-glucuronidase activity of intestinal bacteria. , 1996, Letters in applied microbiology.

[22]  R. Jefferson,et al.  The Escherichia coli gus operon: induction and expression of the gus operon in E. coli and the occurrence and use of GUS in other bacteria. , 1992 .

[23]  J. Nicoli,et al.  Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro , 1993, Applied and environmental microbiology.

[24]  J. Han,et al.  Intestinal bacterial metabolism of flavonoids and its relation to some biological activities , 1998, Archives of pharmacal research.

[25]  B. Drasar,et al.  Bacteria and the aetiology of cancer of the large bowel. , 1969, Gut.

[26]  P. Henderson,et al.  The gusBC Genes of Escherichia coli Encode a Glucuronide Transport System , 2005, Journal of bacteriology.

[27]  P. Wang,et al.  Glucuronides in anti-cancer therapy. , 2003, Current medicinal chemistry. Anti-cancer agents.

[28]  A. Merrill,et al.  Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis. , 1999, Cancer research.

[29]  T. Fujisawa,et al.  Influence of various bile salts on ββ‐glucuronidase activity of intestinal bacteria , 1996, Letters in applied microbiology.

[30]  F. Guéraud,et al.  Glucuronidation: a dual control. , 1998, General pharmacology.

[31]  G. Macfarlane,et al.  Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. , 1998, Journal of medical microbiology.

[32]  S M Burgess,et al.  beta-Glucuronidase from Escherichia coli as a gene-fusion marker. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Hillen,et al.  Carbon catabolite repression in bacteria. , 1999, Current opinion in microbiology.

[35]  G N Shah,et al.  Active site residues of human beta-glucuronidase. Evidence for Glu(540) as the nucleophile and Glu(451) as the acid-base residue. , 1999, The Journal of biological chemistry.

[36]  M. Novel,et al.  Regulation of beta-glucuronidase synthesis in Escherichia coli K-12: constitutive mutants specifically derepressed for uidA expression , 1976, Journal of bacteriology.

[37]  H. W. Scheeren,et al.  Beta-glucuronidase-mediated drug release. , 2002, Current pharmaceutical design.